After functional V(D)J recombination, bone marrow immature B cells express a BCR made up of surface IgM. In secondary lymphoid organs, mature B cells simultaneously express surface IgD of the same specificity as surface IgM through alternative splicing of a pre-mRNA composed of V(D)J and both C~μ~ and C~δ~ heavy chain constant exons ([@bib18]; [@bib28]; [@bib8]). After encountering antigen, in adequate lymphoid tissue structures providing accessory signals (direct interactions with T cells and follicular dendritic cells and binding of cytokines secreted by such cells), activated B cells undergo classical class-switch recombination (cCSR) and substitute the C~μ~ gene with C~γ~, C~α~, or C~ε~, thereby generating secondary IgG, IgA, and IgE BCR and antibody classes with the same antigenic specificity but new effector functions. This recombination targets specific stretches of repetitive DNA (S regions) preceding C~μ~ and all C~γ~, C~α~, and C~ε~ genes and requires the DNA-editing enzyme activation-induced deaminase (AID; [@bib23]). Transcription and, to an even higher extent, accessibility of the IgH locus S regions to cCSR is under the control of the IgH 3′ regulatory region (3′RR), located downstream of Cα, and encompassing the four transcriptional enhancers hs3a, hs1,2, hs3b, and hs4 ([@bib37]; [@bib27]). Genomic disruption or complete deletion of the 3′RR in the mouse abrogates cCSR to all IgG, IgA, and IgE classes ([@bib37],[@bib38]; [@bib27]). Recently the 3′RR was also reported to be transcribed and itself undergo AID-mediated mutation and recombination around phylogenetically conserved switch-like DNA repeats, highlighting its close functional partnership with AID ([@bib24]).

Despite the absence of a repetitive S region upstream of C~δ~ and similar to class switching from IgM to IgG, IgA, and IgE, some CD38^+^ human B cells from tonsils carry an IgH locus switched to IgD expression after an AID-mediated deletion of C~μ~ ([@bib2]; [@bib6]; [@bib16]; [@bib9]). Secreted IgD originating from such cells with CSR from C~μ~ to C~δ~ (μδCSR) enhances immune surveillance and can exert proinflammatory and antimicrobial effects ([@bib9]). Although there is no canonical switch region 5′ to the C~δ~ gene in mammals ([@bib28]; [@bib8]), rudimentary S~δ~-like (σ~δ~) sequences have been described at C~μ~-C~δ~ junctions but CSR from μ to δ stands as a rare event whose regulation is obscure ([@bib8]). To explore the role of the 3′RR on such C~μ~-C~δ~ recombinations, in the context of the endogenous locus, we analyzed IgH 3′RR-deficient mice lacking the 30-kb extent of the 3′RR, a deletion which we previously characterized as inducing a severe cCSR defect toward IgG, IgA, and IgE ([@bib38]), a severe somatic hypermutation (SHM) defect ([@bib32]) but with normal V(D)J recombination ([@bib31]).

RESULTS
=======

IgD secretion in mice occurs at low levels and is poorly understood. Germline transcription of I~μ~-C~μ~ enrolls the S~μ~ regions as a substrate for DNA modification by the cCSR machinery including AID ([@bib8]). I~μ~-C~δ~ transcripts can originate either from alternate splicing of a pre-mRNA encompassing C~μ~ and C~δ~ exons or from primary C~δ~ transcripts after μδCSR. [Fig. 1](#fig1){ref-type="fig"} schematizes these processes and locates PCR primers and probes used in this study.

![**Two pathways for IgD synthesis.** IgD can originate either from the alternate splicing of a pre-mRNA encompassing C~μ~ and C~δ~ exons (left) or from primary C~δ~ transcripts after μδCSR (right). CSR from S~μ~ to σ~δ~ includes germline I~μ~-C~μ~ and I~μ~-C~δ~ transcripts and σ~δ~-S~μ~ switch circles. Arrows located primers used in the study. Numbers and letters refer to the indicated primers and probes, respectively, as reported in Materials and methods.](JEM_20131385_Fig1){#fig1}

μδCSR occurs in normal mesenteric LNs (MLNs) of *wt* mice and 3′RR-deficient mice
---------------------------------------------------------------------------------

μδCSR is currently not documented in mice ([@bib8]). Although little is known about the role of soluble IgD in physiology, a well-known inflammatory disease in humans features high serum IgD levels and was thus called hyper-IgD syndrome, a disease also featuring enlargement of MLNs ([@bib21]). In a search for IgD^+^IgM^−^ cells after μδCSR in *wt* mice, we thus focused our attention on MLN B cells. S regions consist of tandem repeats of short G-rich sequences. While readily showing S~μ~ repeats, dot plot analysis of the mouse DNA fragment encompassing the Eμ enhancer to C~δ~ only revealed few DNA repeats upstream of C~δ~ in a short 0.5-kb-long region that was thereby named σ~δ~ ([@bib28]; [Fig. 2 A](#fig2){ref-type="fig"}). Using a nested PCR-based strategy (location of primers in [Fig. 1](#fig1){ref-type="fig"}) followed by Southern blotting (location of the probe in [Fig. 1](#fig1){ref-type="fig"}) of PCR products, we were able to detect S~μ~-σ~δ~ junctions as a result of S~μ~ to σ~δ~ CSR ([Fig. 2 B](#fig2){ref-type="fig"}). We definitely authenticated S~μ~-σ~δ~ junctions by cloning them and analyzing their sequences ([Fig. 2 C](#fig2){ref-type="fig"} and [Table S1](http://www.jem.org/cgi/content/full/jem.20131385/DC1){#supp1}). Because 3′RR-deficient mice are known to be almost completely defective for cCSR ([@bib38]), we also checked them for μδCSR. To our surprise, Southern blotting of PCR product revealed the presence of S~μ~-σ~δ~ junctions as a result of S~μ~ to σ~δ~ CSR ([Fig. 2 B](#fig2){ref-type="fig"}). These junctions were again authenticated by cloning and sequencing ([Fig. 2 C](#fig2){ref-type="fig"} and Table S1).

![**MLN B cells undergo μδCSR.** (A) DNA dot plot analysis of the genomic sequence encompassing a fragment from the Eμ enhancer to the δ exon 2 from a 129 *wt* mouse (GenBank accession no. [AJ851868.3](AJ851868.3)). The sequence was compared with itself and dots off the diagonal represent repetitive patterns within the sequence. S~µ~ and σδ regions are indicated. (B) Southern blot analysis of S~μ~-C~δ~ junctions amplified by PCR and hybridized with a 5′C~δ~ probe from MLN B cells of 3′RR-deficient mice and *wt* mice. 100 and 20 ng DNA were used for PCR experiments. Data are representative of 6 independent experiments with 1 mouse per group. (C) μδ junctions obtained from *wt* mice (data are pooled from 13 independent experiments with 1 mouse per experiment) and 3′RR-deficient mice (data are pooled from 10 independent experiments with 1 mouse per experiment) were cloned and sequenced. Percentages of junctions with insertion and junctional microhomology are reported. μγ1 and μγ3 junctions from *wt* mice (data are pooled from 6 independent experiments with 1 mouse per experiment) obtained after in vitro LPS ± IL4 stimulation of splenocytes are reported. The sequenced junctions depicted from all the mice combined. (D) Location of S~μ~-σ~δ~ breaks in 13 *wt* and 10 3′RR-deficient mice and S~μ~-S~γ1~ and S~μ~-S~γ3~ breaks during in vitro cCSR in 6 *wt* mice (same junctions and mice as in [Fig. 2C](#fig2){ref-type="fig"}).](JEM_20131385_Fig2){#fig2}

Molecular features of μδCSR junction sequences
----------------------------------------------

The locations of S~μ~-σ~δ~ breaks in S~μ~ and σ~δ~ for *wt* mice and 3′RR-deficient animals are reported in [Fig. 2 D](#fig2){ref-type="fig"}. Among S~μ~-σ~δ~ junctions in *wt* mice ([Fig. 2 C](#fig2){ref-type="fig"} and Table S1), 13/21 (61.9%) showed 1--8-bp-long junctional microhomology. Complex junctions were also frequent (6/21, 28.6%). Similarly to *wt* mice, junctions with short nucleotide insertions and complex junctions were found in 3′RR-deficient mice. Junctions with microhomologies 1--8 bp long represented 45.7% (16/35) of junctions ([Fig. 2 C](#fig2){ref-type="fig"} and Table S1). Complex junctions represented 31.4% (11/35) of junctions. Direct S~μ~-σ~δ~ joining was slightly increased in 3′RR-deficient mice (7/35, 20%) as compared with *wt* mice (2/21, 9.2%). To compare μδCSR junctions cloned from MLN cells from *wt* mice with cCSR junctions, splenocytes from *wt* mice were stimulated with LPS or LPS + IL4 to generate C~μ~-C~γ3~ and C~μ~-C~γ1~ cCSR, respectively ([@bib36]). Sequences of S~μ~-C~γ3~ and S~μ~-C~γ1~ junctions resulting from S~μ~ to S~γ3~ and S~γ1~ cCSR were reported in [Fig. 2 C](#fig2){ref-type="fig"} and Table S1. Features of S~μ~-S~γ~ CSR junctions (i.e., relative frequencies of direct joints, microhomologies, insertions, and complex junctions) were similar to those classically reported ([@bib34]). Sequences from S~μ~-σ~δ~ junctions of *wt* mice showed strikingly different features in that they more rarely exhibited a direct joining (2/21, 9.5%) than either S~μ~-S~γ1~ (12/46, 26.1%) or S~μ~-S~γ3~ (11/70, 15.9%) junctional sequences. Apart from that, the location of S~μ~ breaks was similar in C~μ~-C~δ~, C~μ~-C~γ1~, and C~μ~-C~γ3~ junctions ([Fig. 2 D](#fig2){ref-type="fig"}). Finally, the cloned σ~δ~ breaks were mostly located in the 3′ part of the σ~δ~ region similar to breaks in the downstream part of S~γ1~ and S~γ3~ for cCSR junctions ([Fig. 2 D](#fig2){ref-type="fig"}). The increased representation of DNA breaks in the 5′ part of S~μ~ and the 3′ part of σ~δ~ or S~γ~ might involve a methodological bias whereby PCR cloning of the shortest recombined DNA segment would be favored.

Identical phenotype of IgD^+^IgM^−^ B cells in 3′RR-deficient and *wt* mice
---------------------------------------------------------------------------

Flow cytometry analysis indicated that IgD^+^IgM^−^ B cells accounted for only ∼0.2% of total MLN cells in *wt* mice ([Fig. 3 A](#fig3){ref-type="fig"}). Consistent with published human data ([@bib9]), a low percentage of IgD^+^IgM^−^ B cells expressed CD138 (syndecan-1), a hallmark of mature plasma cells ([Fig. 3, B and C](#fig3){ref-type="fig"}). Furthermore, the vast majority of IgD^+^IgM^−^ B cells did not express surface B220, CD11b, CD19, CD21, and CD23 markers which are usually down-regulated by differentiated plasma cells ([Fig. 3, B and C](#fig3){ref-type="fig"}). IgD^+^IgM^−^ B cells also lacked PNA and GL7 staining and thus differed from germinal center (GC) B cells ([Fig. 3 C](#fig3){ref-type="fig"}). In contrast to human IgD^+^IgM^−^ B cells ([@bib2]; [@bib9]), no bias for surface λ-light chain was found (not depicted). Similarly to human IgD^+^IgM^−^ B cells ([@bib9]), mouse IgD^+^IgM^−^ B cells expressed CD5, an activation-induced B cell molecule ([Fig. 3, B and C](#fig3){ref-type="fig"}), and had a low proliferation rate (Ki67 index of ∼50%; [Fig. 3 C](#fig3){ref-type="fig"}). IgD^+^IgM^−^ B cells were not detected in splenocytes, bone marrow B cells, and circulating B cells of *wt* mice (unpublished data). Flow cytometry analysis indicated the presence of IgD^+^IgM^−^ B cells in MLNs of 3′RR-deficient mice and that they accounted for ∼2% of total MLN cells ([Fig. 3 A](#fig3){ref-type="fig"}), i.e., a 10-fold increase as compared with *wt* mice. Increased IgD switching was also confirmed after Southern blotting of S~μ~-σ~δ~ junctions ([Fig. 2 B](#fig2){ref-type="fig"}). Besides their increased abundance, IgD^+^IgM^−^ B cells from 3′RR-deficient animals qualitatively differed from those in *wt* mice by showing a lower expression of the B cell surface markers B220, CD19, CD21, and CD23 ([Fig. 3, B and C](#fig3){ref-type="fig"}), although they overwhelmingly (80%) expressed CD5 and poorly proliferated (\<40% were Ki67^+^) as for *wt* IgD^+^IgM^−^ cells. Due to their low levels in MLNs, IgD^+^IgM^−^ B cells did not show up in *wt* mice using immunohistochemistry but were detected in 3′RR-deficient mice. In agreement with their PNA^−^ and GL7^−^ status, IgD^+^IgM^−^ cells were located in the marginal zone of GC ([Fig. 4 A](#fig4){ref-type="fig"}) and had a typical ovaloid-elongated plasma cell shape, medium to large size, and an abundant cytoplasm containing C~δ~ IgH chains ([Fig. 4 A](#fig4){ref-type="fig"}). In contrast to humans ([@bib9]), and confirming results with *wt* mice, we did not find any bias in the κ^+^/λ^+^ ratio when specifically studying those cells that express IgD in the absence of IgM expression ([Fig. 4 B](#fig4){ref-type="fig"}). Similarly to *wt* mice, such cells were not detected in blood, bone marrow, spleen, and Peyer's patches of 3′RR-deficent mice (unpublished data). A large fraction of B cells from the anti-mesenteric wall of the mouse small intestine displays an IgD^+^IgM^−^ phenotype ([@bib14]). We confirmed the presence of IgD^+^ B cells by immunostaining all along the mouse small intestine but, again, more noticeably in 3′RR-deficient mice than in *wt* mice ([Fig. 4 C](#fig4){ref-type="fig"}).

![**IgD^+^IgM^−^ B cell phenotype**. (A) Flow cytometry analysis of IgM^−^IgD^+^ cells in MLN of *wt* mice and 3′RR-deficient mice. Cells were fixed and permeabilized before IgM and IgD staining. Cells were first gated on IgM^−^ cells and second on IgD^+^ cells highlighting the presence of IgM^−^IgD^+^ cells. Plots are representative of 6 independent experiments with 1 mouse per group. (B) Cytometry analysis of CD19, CD5, CD138, and CD23/CD21 cell surface markers in IgD^+^IgM^−^ cells from *wt* mice and 3′RR-deficient mice. Plots are representative of 6 independent experiments with 1 mouse per group. (C) Percentage of mouse IgD^+^IgM^−^ cells expressing CD19, CD5, Ki67, CD138, GL7/B220, PNA/Fas, CD11b, and CD21/CD23 in *wt* and 3′RR-deficient mice. Data are the mean ± SEM from 6 independent experiments with 1 mouse per group.](JEM_20131385_Fig3){#fig3}

![**Immunohistochemistry analysis of IgD^+^IgM^−^ cells.** (A) MLN tissue of 3′RR-deficient mice stained for IgM (red), IgD (green), and B220 (blue). Images are representative of 4 independent experiments with 1 mouse per experiment. Bars: (10×) 100 µm; (63×) 10 µm. (B) MLN tissue stained for IgD (green), κ light chain (red), and λ light chain (red) in 3′RR-deficient mice. Images are representative of 4 independent experiments with 1 mouse per experiment. Bars: (10×) 100 µm; (63×) 10 µm. (C) Intestine tissue stained for IgD (green) and IgM (red) in 3′RR-deficient mice and *wt* animals. Images are representative of 4 independent experiments with 1 mouse per group. Bar, 100 µm.](JEM_20131385_Fig4){#fig4}

μδCSR has numerous characteristics of cCSR
------------------------------------------

To ensure whether the IgD^+^ phenotype is linked to μδCSR, PCR analysis of μδCSR in sorted IgD^+^IgM^−^ cells (from three mice) was performed in 3′RR-deficient mice (where these cells are more abundant and accessible to cell sorting). After cloning and sequencing we detected 11 different μδ sequences among 22 analyzed sequences (i.e., 50%). No junctions were found with sorted IgD^−^IgM^+^ cells, reinforcing the hypothesis that the IgD^+^IgM^−^ phenotype is linked to μδCSR. Real-time PCR analysis indicated a dramatic decrease (62%, P = 0.005, Mann-Whitney *U* test) of Cμ transcripts in sorted IgD^+^IgM^−^ cells as compared with sorted IgD^+^IgM^+^ cells, reinforcing the hypothesis that the IgD^+^IgM^−^ phenotype is linked to μδCSR ([Fig. 5 A](#fig5){ref-type="fig"}). During CSR, there are abundant double-strand breaks (DSBs) in Sμ. A fraction of these DSBs may be joined to rare DSBs in other parts of the genome, especially within flanking regions on the same chromosome. To demonstrate a specific association of σδ with μδCSR, PCR analysis was performed with other reverse PCR primers (location in [Fig. 1](#fig1){ref-type="fig"}) corresponding to C~μ~ and a region between C~δ~ and I~γ3~. Using these primers, we were unable to detect any μδ junctions (out of 200 independent junk sequences analyzed) in MLN DNA of four 3′RR-deficient mice with detectable μδCSR, demonstrating that the joining between S~μ~ and σ~δ~ represents a specific recombination event. Using a PCR amplification (location of primers in [Fig. 1](#fig1){ref-type="fig"}), followed by Southern blotting (location of the probe in [Fig. 1](#fig1){ref-type="fig"}), we identified extrachromosomal σ~δ~-S~μ~ circles in MLN B cells of 3′RR-deficient mice ([Fig. 5 B](#fig5){ref-type="fig"}), indicating ongoing μδCSR and a looping-out and deletion mechanism analogous to cCSR (in conditions where ongoing μδCSR was not detectable in MLN DNA from *wt* mice). The identity of the PCR product was confirmed by sequencing (location of primers in [Fig. 1](#fig1){ref-type="fig"}; not depicted). The hallmark of cCSR is its dependence on AID for DSBs formation in S regions. Ligation-mediated PCR (LM-PCR) highlighted the presence of DSBs in σ~δ~ in *wt* mice and 3′RR-deficient mice but not in AID-deficient mice ([Fig. 5 C](#fig5){ref-type="fig"}). Using the same experimental strategy as for *wt* and 3′RR-deficient mice, we were unable to detect any S~μ~-σ~δ~ junction in genomic DNA from MLNs of AID-deficient mice by Southern blotting of PCR products designed to amplify such junctions ([Fig. 5 D](#fig5){ref-type="fig"}). Despite the lack of significant hybridization, we further tried to clone potential junctions from AID-deficient mice (by the same protocol as for *wt* mice) and failed to identify any (out of 288 independent junk sequences analyzed) indicating that μδCSR in mice requires AID as previously suggested by analyses in human AID-deficient patients ([@bib2]; [@bib9]). Finally, an I~μ~-C~δ~ transcript was previously identified in human ([@bib9]). Real-time PCR analysis confirmed its presence not only in IgD^+^IgM^+^ (where it can originate from alternate splicing of a pre-mRNA encompassing C~μ~ and C~δ~ exons) but also in IgD^+^IgM^−^ where it is the reflect of the post-IgD CSR transcription ([Fig. 5 E](#fig5){ref-type="fig"}).

![**μδCSR in 3′RR-deficient mice.** (A) Real-time PCR analysis of membrane C~μ~ transcripts in sorted IgD^+^IgM^+^ and IgD^+^IgM^−^ cells from 3′RR-deficient mice. Data are the mean ± SEM of 7 independent experiments with 1 mouse and 8 independent experiments with 1 mouse for IgD^+^IgM^+^ and IgD^+^IgM^−^ cells, respectively. \*, P \< 0.01 (Mann-Whitney *U* test). (B) Southern blot analysis of σ~δ~-S~μ~ switch circles amplified by PCR and hybridized with a C~μ~-labeled probe from MLN B cells of 3′RR-deficient and *wt* mice. Results from four mice (lines 1--4) in each group are reported. Data are representative of 6 independent experiments with 1 mouse per group. (C) LM-PCR. Genomic DNA from *wt*, 3′RR-deficient, and AID-deficient mice were left untreated or treated with T4 DNA polymerase (T4 Pol), ligated with T4 DNA ligase and probed for double-stranded breaks in σδ after by semi-nested PCR. Reactions with 100 and 20 ng DNA are shown. Data are representative of 6 independent experiments each with 1 mouse per genotype. (D) Southern blot analysis of S~μ~-C~δ~ junctions amplified by PCR and hybridized with a 5′C~δ~ probe from MLN B cells of *wt* mice and AID-deficient mice. 100 and 20 ng DNA were used for PCR experiments. Data are representative of 6 independent experiments with 1 mouse per group. (E) Real-time PCR analysis of I~μ~-C~δ~ transcript in sorted IgD^+^IgM^+^ and IgD^+^IgM^−^ cells from 3′RR-deficient mice. Data are of the mean ± SEM of 6 independent experiments with 1 mouse and 8 independent experiments with 1 mouse for IgD^+^IgM^+^ and IgD^+^IgM^−^ cells, respectively. ns = not significant.](JEM_20131385_Fig5){#fig5}

Mutations in IgD^+^IgM^−^ cells
-------------------------------

Interactions with cognate antigens recruit activated B cells into GC and can induce AID-mediated modifications. These include SHM in V(D)J exons for the generation of high-affinity antibodies and cCSR ([@bib15]; [@bib11]; [@bib13]). cCSR and SHM are linked to transcription, dependent from some common actors, and both blocked by AID deficiency. SHM can also be considered as the usual mark for antigen-experienced B cells having participated to a GC reaction ([@bib7]). We purified IgD^+^IgM^−^ cells from 3′RR-deficient mice (where these cells are more abundant and accessible to cell sorting) to evaluate VκJκ SHM and identify them as pre- or post-GC B cells. To stimulate SHM, mice were immunized both orally with sheep red blood cells and intraperitoneally with LPS (i.e., in conditions known to yield in vivo activated spleen and Peyer's patches B cells with VκJκ SHM both in *wt* and 3′RR-deficient mice; [@bib24]; [@bib32]). Rearranged IgH VDJ and VκJκ regions from MLN IgD^+^IgM^−^ cells of 3′RR-deficient mice were cloned and sequenced. No SHM could be documented out of 90 VDJ sequences analyzed (3 mutations among 68,582 bp analyzed, 0.0044%) and 58 κ sequences analyzed (7 mutations among 36,134 bp analyzed, 0.0194%). Although the absence of SHM in VDJ rearranged region was expected in 3′RR-deficient mice recently demonstrated with and IgH locus-specific SHM defect ([@bib32]), the lack of SHM in the κ light chain locus clearly indicate that those B cells with μδCSR have not undergone conventional antigen-driven maturation as usually occurring into GC. By comparison, 3′RR-deficient animals recently analyzed after the same immunization protocol showed a \>70-fold higher (1.39%) SHM rate in VκJκ segment from Peyer's patches GC B cells ([@bib32]). The lack of mutation in VDJ segments fitted well with their PNA^−^GL7^−^ status and their localization in the marginal zone of GC. Contrasting with mice, human IgD^+^IgM^−^ had extensive SHM in their IgV genes that indicated their clonal relatedness ([@bib2]). Mouse IgD^+^IgM^−^ had no SHM in their IgV genes and the use of a J~H4~ probe on Southern blots from IgD^+^IgM^−^ cell DNA revealed no rearranged bands in addition to the germline band indicating no potential clonal relatedness (unpublished data). We finally analyzed mutations during μδCSR in *wt* mice as compared with cCSR to find if intensity of AID attack is similar between them. The mutation frequency at S~μ~ breakpoints and 5′ to S~μ~ breakpoints were lower in μδCSR than in IgG~1~ and IgG~3~ cCSR (although the latter control was chosen using in vitro conditions poorly inducing SHM; [Fig. 6, A and B](#fig6){ref-type="fig"}). A decrease of 25 and 52% in the frequency of mutations in the S~μ~ donor region was found during μδCSR as compared with IgG~3~ and IgG~1~ cCSR, respectively. The numbers of mutations at σ~δ~ breakpoints and 3′ to σ~δ~ breakpoints were also much lower than in target S~γ~ region of cCSR (a decrease of 89 and 86% of those found in S~γ1~ and S~γ3~, respectively; [Fig. 6, A and B](#fig6){ref-type="fig"}). Thus, not only the S~μ~ donor region but also the σ~δ~ acceptor region implicated in μδCSR exhibited lower AID-induced mutations than S~μ~, S~γ1~, and S~γ3~ during IgG~1~ and IgG~3~ cCSR. Interestingly, the pattern of mutations at S~μ~-σ~δ~ junctions, 5′ to S~μ~, and 3′ to σ~δ~ was similar in *wt* mice and 3′RR-deficient animals ([Fig. 6 B](#fig6){ref-type="fig"}), showing that the absence of the 3′RR did not affect the AID-targeting at the S~μ~ donor and σ~δ~ acceptor regions during μδCSR.

![**Mutation in S~μ~ and σ~δ~ during μδCSR.** Mutation frequency in the donor region (S~μ~) and the acceptor region (σ~δ~, S~γ1~, or S~γ3~) during μδCSR and cCSR. (A) Mutation frequency per mutated bp. 46 S~μ~-C~γ1~, 69 S~μ~-C~γ3~, and 21 S~μ~-C~δ~ junctions from *wt* mice were investigated. S~μ~-C~γ1~ and S~μ~-C~γ3~ junctions were obtained after in vitro stimulation of splenocytes from *wt* mice (data are pooled from 6 independent experiments with 1 mouse). S~μ~-C~δ~ junctions were obtained after genomic extraction of MLN from *wt* mice (data are pooled from 13 independent experiments with 1 mouse). (B) Number of mutation in each S acceptor and S donor regions. 35 S~μ~-C~δ~ junctions were obtained after genomic extraction of MLN from 3′RR-deficient mice (data are pooled from 10 independent experiments with 1 mouse).](JEM_20131385_Fig6){#fig6}

DISCUSSION
==========

cCSR is a very complex process during which accessibility to recombination is regulated by both cis-acting factors (such as germline I promoters and 3′RR enhancers) and trans-acting factors (most of which are induced by cytokine-dependent signals and/or B cell activation; [@bib34]; [@bib5]). Analysis of DNA sequence at or around the recombination sites has helped us to understand the mechanisms first generating DSBs after targeting of S regions by AID and then allowing synapsis and repair of chromosomal breaks mostly through a classical nonhomologous end joining (C-NHEJ) pathway or to a lower extend through the alternative end-joining (A-EJ) pathway ([@bib40]; [@bib5]). Although various disruptions of the 3′RR partially compromised cCSR ([@bib10]; [@bib17]; [@bib26]; [@bib36]; [@bib3]), its complete deletion has clarified its mandatory role for cCSR toward IgG, IgA, and IgE isotypes ([@bib38]) as well as for SHM in rearranged VDJ exons ([@bib32]).

Phylogenetic studies indicate that IgD is as ancient as IgM but, in contrast to IgM, IgD is evolutionarily labile showing, for instance, many duplications/deletions of domains and splice forms ([@bib19]; [@bib29]). Due to the lack of an authentic S~δ~ region, B cells exclusively expressing IgD are extremely rare in humans and almost absent in mice ([@bib22]). Our study clearly shows that despite the lack of canonical S~δ~ region, CSR from μ to δ occurs in MLNs from *wt* mice. Sequences of μδCSR junctions reveal a lower percentage of direct end junctions in μδCSR than in cCSR together with a higher percentage of junctions with either microhomologies between recombined ends or showing insertions of various lengths at the recombination site. Notably, this pattern is strongly reminiscent of the junctions affected by the A-EJ pathway and previously reported during cCSR in B cells lacking key components of the C-NHEJ pathway, its main characteristic being a dramatic reduction of CSR direct joints and frequent junctions with microhomologies and insertions ([@bib40]). Although the A-EJ pathway has only recently been shown to contribute to cCSR, it has been shown that in the absence of C-NHEJ, cCSR can be performed by A-EJ at up to 50% of *wt* levels ([@bib40]). Notably, the same A-EJ--based pattern of junctions is also observed when referring to a few mouse IgD-secreting hybridomas documented in the past ([@bib22]).

Similarly to cCSR, the absence of μδCSR in AID-deficient mice confirms it also requires AID. The hallmark of CSR is its dependence on AID for DSBs formation in S regions. LM-PCR experiments found the presence of DSBs in σ~δ~ in *wt* mice and 3′RR-deficient mice but not in AID-deficient mice. μδCSR is also AID-dependent in human ([@bib9]). However, this does not imply that all IgD-producing plasma cells have undergone μδCSR. Indeed, serum IgD persists and is even augmented in some AID-deficient patients, probably as a result of the activation of an alternative pathway involving the emergence of plasma cells that produce both IgM and IgD via alternative splicing, particularly at mucosal sites ([@bib9]). Our data indicated that during μδCSR the S~μ~ and (still more clearly) the σ~δ~ acceptor region are less actively targeted by AID than S~μ~, S~γ1~, and S~γ3~ during IgG~1~ and IgG~3~ cCSR. This suggests, aside from differences in junction diversity, that μδCSR is regulated differently from cCSR. Individual S regions range in size from 10 kb for S~γ1~ (IgG~1~ being the most abundant Ig class) to 2.5 kb for S~γ3~ and to only 1 kb for S~ε~. Studies pointed the S region size as an important factor in determining endogenous cCSR efficiency because cCSR frequencies correlated with S region length ([@bib43]). The very low level of μδCSR in *wt* mice may be linked to the short length (0.5 kb) of the σ~δ~ region and to a less active targeting by AID than S~γ1~ and S~γ3~ during cCSR.

An intronic (I) exon is positioned upstream of each C~H~ gene except C~δ~ both in mice and humans. I~H~-C~H~ germinal transcripts render S~H~ regions substrate for DNA modifications by the CSR machinery, including AID. As previously identified in humans ([@bib9]), an I~μ~-C~δ~ transcript is identified in mice. This I~μ~-C~δ~ transcript is of importance to render both S~μ~ and σ~δ~ regions substrate for DNA modifications, especially because no I~δ~ exon is documented in the mouse and the human IgH locus. In contrast to mice and humans, an I~δ~ exon has been recently reported in the bovine IgH locus ([@bib39]). This I~δ~ exon derives from the recent duplication of an I~μ~-C~μ~1 genomic fragment ([@bib44]). Of interest, the bovine δ gene can be expressed by CSR; analysis of S~μ~-S~δ~ junctions demonstrated, as in mice, a preference for using the microhomology-based end-joining pathway ([@bib39]). After μδCSR, I~μ~-C~δ~ transcripts are still detected and are the reflection of the post-IgD CSR transcription and not simply a germinal transcript of importance to render both S~μ~ and σ~δ~ regions substrate to CSR-induced DNA modifications.

The 3′RR is mandatory for cCSR toward IgG, IgA, and IgE isotypes ([@bib38]). This is obviously not the case for IgD. Patients with hyper-IgM syndromes have higher μδCSR that may stand as a compensatory response due to the absence of other switched isotypes ([@bib8]). It appears that deletion of the 3′RR, most probably through a compensatory response due to the absence of other switched isotypes, enhances IgD CSR without widely impacting the patterns of S~μ~-σ~δ~ junctions. Thus, AID-induced μδCSR occurs independently of the IgH 3′RR, a result that markedly contrasts with S~μ~-S~γ~, S~μ~-S~ε~, and S~μ~-S~α~ cCSR. The lower AID-induced mutations both in S~μ~ and σ~δ~ region during μδCSR (as compared with those in S~μ~, S~γ1~, and S~γ3~ during S~μ~-S~γ1~ and S~μ~-S~γ3~ cCSR) suggest that AID might be recruited to the IgH locus by different means than cCSR. This result partially fits with recent data showing, in addition to cCSR, that the 3′RR is also a key element for AID recruitment during AID-induced SHM both in VDJ-expressed sequences and S~μ~ ([@bib32]). The analysis of SHM in VDJ expressed sequences of 3′RR-deficient B cells that have undergone μδCSR confirms that the 3′RR is essential to the SHM process on V(D)J exons and that a physiological dissociation exists between SHM and CSR in primary B cells of 3′RR-deficient mice as in T cell--independent responses ([@bib25]).

CSR to IgD is obviously a rare event and we now show that it occurs independently of the IgH 3′RR. It might be of interest to notice that in this special case, and in contrast to SHM of VDJ and of S~μ~ regions during cCSR, the rate of mutations affecting the target regions of μδCSR is not affected by the 3′RR deletion. This observation, together with the unique location of IgD switching only in the mucosa-associated lymphoid tissue, argues for a specific regulation of this event, allowing AID recruitment to the IgH locus in a 3′RR-independent manner and in response to stimuli that remains to be determined. Transcription being required for AID targeting, the simultaneous accessibility of S~μ~ and σ~δ~ to AID likely needs constitutive I~μ~-C~δ~ transcription (encompassing both S~μ~ to σ~δ~). However, because I~μ~-C~δ~ transcription is common in all naive B cells and during their initial entry into GC, it is obviously not sufficient by itself for inducing accessibility to μδCSR and another stimulus uniquely occurring into mouse MLNs and into human tonsils likely allows the 3′RR-independent recruitment of AID on the IgH locus in some B cells. Until now, our knowledge concerning μδCSR in mice only derived from studies of myeloma and hybridoma cell lines ([@bib22]; [@bib28]). 3′RR-deficient mice give us the first opportunity to investigate it in primary B cells.

Location of IgD^+^IgM^−^ cells in the marginal zone, but not in the follicular zone, together with their PNA^−^GL7^−^ status and their lack of SHM in the VDJ segment might be suggestive of T cell--independent non-GC origin for cells with μδCSR, as previously documented in physiology for some mucosa-associated lymphoid tissue B cells undergoing T cell--independent IgA CSR ([@bib4]). In addition, cCSR in the absence of SHM was reported in some cases of chronic lymphocytic leukemia B cells ([@bib20]) upon N-terminal mutation of AID ([@bib33]) and, recently, in *Ung*^−/−^ mice during an acute antigenic challenge ([@bib41]). Our data with μδCSR further indicates that AID can be recruited to the IgH locus under various different forms, eventually associated with some different partners to mediate either cCSR and VDJ SHM (both processes requiring the 3′RR), or in the present case μδCSR (where the 3′RR is at least superfluous; [@bib30]). According to the concept that such IgD-only cells may locally participate in immune surveillance against pathogens present at mucosal sites, their increase in 3′RR-deficient mice with an IgA production defect might be a compensatory mechanism as previously suggested in IgA-deficient patients ([@bib6]).

IgD^+^IgM^−^ B cells in mice exhibited numerous similarities with human ones. Consistent with published human data ([@bib9]), they were CD138^−^, expressed the activation-induced (or B1 compartment-related) molecule CD5, and down-regulated several B cell--specific markers usually down-regulated by differentiated plasma cells. Whether human IgD^+^IgM^−^ cells show a strong bias toward the preferential expression of the λ-light chains ([@bib2]; [@bib9]), it is not the case in mice, a result which might be linked to the κ^+^/λ^+^ ratio, globally reported in mouse B cells around 95/5 ([@bib1]). Whether human IgD^+^IgM^−^ cells are reported to have undergone extensive SHM and display clonal relatedness ([@bib2]), mice IgD^+^IgM^−^ cells are unmutated in their VDJ regions with no evident sign of clonality. These latter results are in accordance with their localization in the marginal zone of GC, a region with cells not submitted to an intensive SHM process or exhibiting a high rate of proliferation (mice IgD^+^IgM^−^ cells had a low Ki67 index).

In conclusion, IgD CSR occurs in B cells of MLNs of *wt* mice. There is extensive somatic mutation of the IgH V region in human IgD^+^ cells ([@bib2]) but not in mouse. The effects of physiological location of switching cells might explain this difference as well as the structural differences in mouse and human 3′ RR. The molecular features of S~μ~-σ~δ~ junctions suggest a predominant involvement of the A-EJ pathway in this process. In contrast to IgG, IgA, and IgE classes, IgD CSR occurs independently of the IgH 3′RR and now stands as an amazing exception contrasting with all the other AID-dependent modifications of the IgH locus previously shown to formally involve the 3′RR in mouse B cells.

MATERIALS AND METHODS
=====================

### Mice.

Generation of 3′RR-deficient mice has been previously reported ([@bib38]). *wt* mice and 3′RR-deficient mice were 8--12 wk old except when specified. Mice were bred and maintained under specific pathogen-free conditions. Mice immunizations were done orally with sheep red blood cells for 2 wk and intraperitoneally with 10 µg LPS for 3 d.

### Cell cytometry analysis.

Single-cell suspensions from MLNs were fixed and permeabilized with the Intraprep permeabilization reagent (Beckman Coulter) before incubation with FITC-labeled IgD (SouthernBiotech) or irrelevant antibody and analyzed on a Fortessa LSR2 (BD; [@bib35]; [@bib36]). Phenotyping of IgD^+^IgM^−^ cells were made with the following antibodies: v450-IgD, APC-IgM, FITC-B220, FITC-CD5, PE-CD11b, PE-CD19, PE-CD21, PC7-CD23, PE-CD138, PE-GL7 and FITC-PNA, and PE-Fas and FITC-Ki67.

### Dot plot analysis.

Dot plot analysis of the mouse DNA fragment encompassing the 5′ Eμ intronic enhancer and the C~δ~ exon 2 was done with the Nucleic Acid Dot Plot Program. Window size and mismatch limit were set to 23 and 3, respectively.

### Amplification, cloning, and sequencing of S~μ~-σ~δ~ junctions.

S~μ~-σ~δ~ junctions were studied using a touchdown PCR, followed by a nested PCR on fresh MLN cells using the following parameters. Touchdown PCR: primer 1, 5′-CAGTTGAGGCCAGCAGGT-3′ and primer 2, 5-CCAATTACTAAACAGCCCAGGT-3′ (1 cycle, 98°C for 3 min; 3 cycles, 98°C for 30 s, 64°C for 40 s, and 72°C for 90 s; 3 cycles, 98°C for 30 s, 62°C for 40 s, and 72°C for 90 s; 25 cycles, 98°C for 30 s, 60°C for 40 s, and 72°C for 90 s; and 1 cycle, 72°C for 7 min). Nested PCR: primer 3, 5′-CAGGTCGGCTGGACTAACTC-3′ and primer 4, 5′-CAGCCCAGGTTTATCTTTTCA-3′ (1 cycle, 98°C for 3 min; 35 cycles, 98°C for 30 s, 65°C for 40 s, and 72°C for 90 s; and 1 cycle, 72°C for 7 min). The PCR products were cloned into the Zero Blunt Topo PCR cloning (Invitrogen). Plasmids were isolated using the NucleoSpin kit (Macherey-Nagel Eurl) and sequenced using an automated laser fluorescent ANA ABI-PRISM sequencer (Perkin-Elmer; [@bib12]). To demonstrate a specific association of σδ with μδCSR, nested PCR analysis was carry out with sense 1 and sense 3 primers and other reverse PCR primers corresponding to Cμ (primer 18, 5′-GTGGGACGAACACATTTACATTGG-3′ and primer 19, 5′-GTTCATCTCTGCGACAGCTG-3′) and a region between Cδ and Iγ3 (primer 20, 5′-GCTCATAGCCTCCTTAGGTTCC-3′ and primer 21, 5′-GAGACTGTTCACTCTATCTTTACCAC-3′).

### Amplification, Southern blotting, and sequencing of μδCSR circles.

μδCSR circles were amplified by PCR using the following parameters: primer 6, 5′-GGACTCGTCACCAAATTCCA-3′ (located at the beginning of σ~δ~) and primer 7, 5′-GAAGACATTTGGGAAGGACTGACT-3′ (located in Cμ exon 1; 1 cycle, 95°C for 2 min; 40 cycles, 95°C for 15 s, 55°C for 20 s, and 72°C for 180 s; and 1 cycle, 72°C for 7 min). Hybridization of μδCSR circles was performed with a 240 bp probe (probe B) located in the Cμ exon1 ([@bib24]). The Cμ exon1 probe was cloned as a PCR fragment according to the following parameters: primer 8, 5′-CGTTCGAAGAAGGCTTCCAAAGTC-3′ and primer 9, 5′-TTATCGATGAGGACCAGAGAGGG-3′ (1 cycle, 94°C for 3 min; 30 cycles, 94°C for 30 s, 55°C for 30 s, and 72°C for 30 s; and 1 cycle, 72°C for 7 min). The circle PCR products were cloned into the Zero Blunt Topo PCR cloning (Invitrogen) and sequenced with and ANA ABI-PRISM sequencer (Perkin-Elmer; [@bib12]).

### Southern blotting of C~μ~-C~δ~ junctions.

C~μ~-C~δ~ junctions were studied after hybridization with a ^32^P-labeled probe (460 bp length, probe A). This C~δ~ probe was cloned as a PCR fragment located in-between primer 5 (5′-CCCAGAACCTGAGAAGGAAG-3′), located in the intron 5′ of C~δ~ and primer 4 (5′-CAGCCCAGGTTTATCTTTTCA-3′), located in C~δ~ exon 1 (1 cycle, 94°C for 3 min; 30 cycles, 93°C for 45 s, 52°C for 45 s, and 72°C for 30 s; and 1 cycle, 72°C for 7 min).

### DNA extraction and amplification for SHM experiments.

Genomic DNA was extracted from sorted B220^+^IgD^+^IgM^−^ cells (85% of purity). IgH VDJ-rearranged fragments were amplified by PCR using the following primers and multistep programs as previously reported ([@bib32]): primer 10, 5′-GCGAAGCTTARGCCTGGGRCTTCAGTGAAG-3′ complementary to the VHJ558 segment and primer 11, 5′-AGGCTCTGAGATCCCTAGACAG-3′ corresponding to a sequence 517 bp downstream of the J~H4~ segment using 1 cycle (98°C for 30 s), 33 cycles (98°C for 10 s, 67°C for 30 s, and 72°C for 90 s), and 1 cycle (72°C for 10 min). Igκ light chain VJ-rearranged fragments were amplified by PCR as previously reported ([@bib32]) using the following primers and multistep programs: primer 12, 5′-GGCTGCAGSTTCAGTGGCAGTGGRTCWGGRAC-3′ (consensus for Vκ) and primer 13, 5′-AGCGAATTCAACTTAGGAGACAAAAGAGAGAAC-3′ (found 557 bp downstream of the J~κ5~ segment) using 1 cycle at 98°C for 30s, 33 cycles (98°C for 10 s, 66°C for 30 s and 72°C for 90 s), and 1 cycle at 72°C for 10 min. PCR products were cloned and sequenced as described ([@bib12]).

### Immunohistochemistry.

Frozen 8-µm sections were thawed at room temperature and dried before being hydrated in PBS. Slides were fixed with cold acetone for 20 min at −20°C, dried for 10 min, and incubated with PBS BSA 3% for 45 min. Rat anti--mouse APC-CD45R (BD; clone RA3-6B2, 560472), rat anti--mouse Alexa Fluor 488--IgD (BioLegend; clone 11-26c-2a, 405718), and rat anti--mouse PE-IgM (eBioscience; clone II/41, 17--5790-82) were used at 1:50 for 1 h at 37°C in PBS BSA 0.3%. Goat anti--mouse κ (Beckman Coulter; 731871) or anti--mouse λ (SouthernBiotech; 1060--01) was used at 1:100 and revealed with a DyLight 594 rabbit anti--goat IgG (Thermo Fisher Scientific; 072--09-13-06) used at 1:250. Slides were mounted with moviol medium.

### Real-time PCR analysis of membrane C~μ~ and I~μ~-C~δ~ transcripts.

Total RNA was prepared from freshly isolated IgD^+^IgM^−^ and IgD^+^IgM^+^ MLN B cell. Reverse transcription was performed with 500 ng of total RNA. RT-PCR experiments were done with SuperScript III reverse transcription (Invitrogen). Real-time PCR analysis (on an ABI Prism 7000 system; Applied Biosystems) was made with the Syber Green method using 10 ng cDNA using the following primer: I~μ~ primer 14, 5′-CTCTGGCCCTGCTTATTGTTG-3′ and C~δ~ primer 15, 5′-GCTCCCAGCTGATTTTCAGT-3′; μ membrane primer 16 (in exon μ 4), 5′-TGGAACTCCGGAGAGACCTA-3′ and μ membrane primer 17 (in exon μ membrane 1), 5′-TTCCTCCTCAGCATTCACCT-3′. GAPDH was used for normalization of gene expression levels (TaqMan reference Mm99999915-g1).

### Spleen cell cultures for CSR.

Single-cell suspensions of spleen cells were cultured 3 d at 10^6^ cells/ml in RPMI 1640 with 10% FCS and 20 µg/ml LPS, with or without addition of 20 ng/ml IL-4 (PeproTech). 3-d in vitro--stimulated splenocytes were harvested and DNA was extracted for investigation of S~μ~-S~γ1~ and S~μ~-S~γ3~ junctions ([@bib36]).

### LM-PCR.

Genomic DNA from *wt* mice, 3′RR-deficient mice, and AID-deficient mice was extracted and purified using Phase Lock gel. 10 µg was treated with T4 DNA polymerase (New England Biolabs, Inc.), which trims back 3′ overhangs while filling in 3′-recessed ends, thereby yielding blunt 5′-phosphorylated DNA ends. 1 µg DNA was then ligated with T4 DNA ligase (New England Biolabs, Inc.) in a 20-µl reaction volume with the double-strand anchor linker BW ([@bib42]). DSBs were detected by semi-nested LM-PCR using BW1 primer targeting the BW linker sequence (5′-GCGGTGACCCGGGAGATCTGAATTC-3′) and primer 2, specific to σδ (5′-CCAATTACTAAACAGCCCAGGT-3′), using the following parameters: (1 cycle, 94°C for 30 s; 25 cycles, 94°C for 10 s, 55°C for 20 s, and 65°C for 2 min; and 1 cycle, 65°C for 7 min). DSBs were studied after hybridization with the same ^32^P-labeled probe as for Southern blotting of C~µ~-C~δ~ junctions.

### Clonality assay.

Genomic DNA prepared from IgD^+^IgM^−^ cells of 3′RR-deficient mice was digested with EcoRI and analyzed by Southern blot with a ^32^P-labeled J~H~ probe ([@bib35]).

### Online supplemental material.

[Table S1](http://www.jem.org/cgi/content/full/jem.20131385/DC1){#supp2} shows S~μ~-σ~δ~, S~μ~-S~γ1~, and S~μ~-S~γ3~ junctions.
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